In CKD patients and kidney transplant recipients, iron deficiency is an important determinant of total FGF23 levels, which has a significant impact on the progression and mortality of CKD (Eisenga et al., 2017; Eisenga et al., 2019). This evidence concerns the gene FGF23 and Iron deficiency anemia.